Skip to content
VC FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 12 SOURCES

Odyssée Venture

Also known as ODYSSEE Venture, Odyssee Venture SAS

Paris investment manager founded in 1999; invests €1–10M of equity and quasi-equity in French growth companies, from start-up to pre-IPO, through FCPI, FIP and FCPR funds sold to private investors.

HEADQUARTERS
Paris, France
FOUNDED
1999
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
1 people

Focus

STAGES
SeedSeries ASeries BGrowth
ASSET MIX
Venture capitalPrivate equity
GEOGRAPHY
France

Overview

Odyssée Venture is an independent Paris portfolio management company created in November 1999 by Mathieu Boillet and Sébastien Sassolas and authorised by the AMF on 1 December 1999 (GP99036). It invests €1–10M in equity and quasi-equity in French growth companies from start-up to pre-IPO and says it has financed nearly 200 French SMEs over 25 years. Its funds are tax-advantaged FCPI, FIP and FCPR vehicles distributed to private investors through partner distributors.

PORTFOLIO (12)

  • Meelo
    Fintech
  • BrightHeart
    HealthTech · since 2026
  • THX Pharma
    Biotech & Life Sciences · since 2025
  • Veragrow
    Food & Agriculture · since 2025
  • Imogate
    Software & SaaS · since 2025
  • Terratis
    Biotech & Life Sciences · since 2024
  • Hoffmann Green Cement
    Climate & Energy · since 2024
  • La Blanchisserie de Paris
    Industrial & Manufacturing · since 2024
  • Veesion
    Artificial Intelligence
  • Kameleoon
    Software & SaaS
  • Evoliz
    Software & SaaS · Sold to Visma (2025)
  • Supervizor
    Software & SaaS · Exited (2024)

People

  • Mathieu Boillet
    Co-founder; legal representative · source

Links

Frequently asked questions

Odyssée Venture is a VC fund based in Paris, France, founded in 1999.

Yes. Odyssée Venture invests its own capital in private companies.

Odyssée Venture invests at Seed, Series A, Series B and Growth stages in Software & SaaS, Artificial Intelligence, HealthTech, Biotech & Life Sciences, Industrial & Manufacturing, Consumer & E-commerce and Climate & Energy.

Odyssée Venture's stated ticket size is €1M–€10M.

Key people at Odyssée Venture include Mathieu Boillet (Co-founder; legal representative).

Odyssée Venture's investments include Meelo, BrightHeart, THX Pharma, Veragrow, Imogate, Terratis, Hoffmann Green Cement and La Blanchisserie de Paris, among others.

The most recent publicly reported investment by Odyssée Venture is Meelo (€14M from the Fonds Stratégique des Transitions (managed by ISALT) plus reinvestment by Odyssée funds), announced in Feb 2026.

Yes. Odyssée Venture manages capital from outside investors.